The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Biomarker Changes during 20 Years Preceding Alzheimer’s Disease
Abstract
Background Biomarker changes that occur in the period between normal cognition and the diagnosis of sporadic Alzheimer's disease have not been extensively investigated in longitudinal studies. Methods We conducted a multicenter, nested case-control study of Alzheimer's disease biomarkers in cognitively normal participants who were enrolled in the China Cognition and Aging Study from January 2000 through December 2020. A subgroup of these participants underwent testing of cerebrospinal fluid (CSF), cognitive assessments, and brain imaging at 2-year-to-3-year intervals. A total of 648 participants in whom Alzheimer's disease developed were matched with 648 participants who had normal cognition, and the temporal trajectories of CSF biochemical marker concentrations, cognitive testing, and imaging were analyzed in the two groups. Results The median follow-up was 19.9 years (interquartile range, 19.5 to 20.2). CSF and imaging biomarkers in the Alzheimer's disease group diverged from those in the cognitively normal group at the following estimated number of years before diagnosis: amyloid-beta (Aβ) 42 , 18 years; the ratio of Aβ 42 to Aβ 40 , 14 years; phosphorylated tau 181, 11 years; total tau, 10 years; neurofilament light chain, 9 years; hippocampal volume, 8 years; and cognitive decline, 6 years. As cognitive impairment progressed, the changes in CSF biomarker levels in the Alzheimer's disease group initially accelerated and then slowed. Conclusions In this study involving Chi…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A recent study indicated that within 20 years, abnormalities in CSF Aβ42, the ratio of CSF Aβ42 to Aβ40, CSF P-tau181, CSF T-tau, CSF neurofilament light chain (NfL), and hippocampal volume (as detected by sMRI) appear in sequence before the clinical diagnosis of SAD.375”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [375]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Measuring the thickness of the human cerebral cortex from magnetic resonance images
Fischl, B., & Dale, A. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200033797 · Cited by 5,818
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204
Vrieze, S. I. (2012) · Psychological Methods · doi:10.1037/a0027127 · Cited by 1,948
Mild cognitive impairment: a concept in evolution
Petersen, R. C., Caracciolo, B., Brayne, C., Gauthier, S., Jelic, V., & Fratiglioni, L. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12190 · Cited by 1,694
Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia: A Meta-analysis
Jansen, W. J., Ossenkoppele, R., Knol, D. L., Tijms, B. M., Scheltens, P., Verhey, F. R. J., Visser, P. J., Aalten, P., Aarsland, D., Alcolea, D., et al. (2015) · JAMA · doi:10.1001/jama.2015.4668 · Cited by 1,610
Cited by
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selbæk, G., Alladi, S., Ames, D., Banerjee, S., Burns, A., Brayne, C., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01296-0 · Cited by 3,860
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Jack, C. R., Andrews, J. S., Beach, T. G., Buracchio, T., Dunn, B., Graf, A., Hansson, O., Ho, C., Jagust, W., McDade, E., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13859 · Cited by 2,803
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
Self-citationOh, H. S., Urey, D. Y., Karlsson, L., Zhu, Z., Shen, Y., Farinas, A., Timsina, J., Duggan, M. R., Chen, J., Guldner, I. H., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03565-2 · Cited by 157
Alzheimer's disease outlook: controversies and future directions
Frisoni, G. B., Aho, E., Brayne, C., Ciccarelli, O., Dubois, B., Fox, N. C., Frederiksen, K. S., Gabay, C., Garibotto, V., Hofmarcher, T., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01389-3 · Cited by 135
The China Alzheimer Report 2025
Zhi, N., Ren, R., Qi, J., Liu, X., Yun, Z., Lin, S., Hu, Y., Li, H., Xie, X., Wang, J., et al. (2025) · General Psychiatry · doi:10.1136/gpsych-2024-102020 · Cited by 117
Self-citationHandelsman, Y., Anderson, J. E., Bakris, G. L., Ballantyne, C. M., Bhatt, D. L., Bloomgarden, Z. T., Bozkurt, B., Budoff, M. J., Butler, J., Cherney, D. Z. I., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155931 · Cited by 103
Alzheimer’s disease as type 3 diabetes: understanding the link and implications
Kciuk, M., Kruczkowska, W., Gałęziewska, J., Wanke, K., Kałuzińska-Kołat, Ż., Aleksandrowicz, M., & Kontek, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252211955 · Cited by 98
Multi-target drugs for Alzheimer's disease
Turgutalp, B., & Kızıl, Ç. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.05.005 · Cited by 92
Neurotoxic β-amyloid oligomers cause mitochondrial dysfunction—the trigger for PANoptosis in neurons
Meng, X., Song, Q., Liu, Z., Liu, X., Wang, Y., & Liu, J. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1400544 · Cited by 88
Self-citationLi, Y., Liu, Y., Yu, X., Xu, Y., Pan, X., Sun, Y. E., Wang, Y., Song, Y.-H., & Shen, Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02013-w · Cited by 95
Self-citationThe Brain–Gut Axis, an Important Player in Alzheimer and Parkinson Disease: A Narrative Review
Caradonna, E., Nemni, R., Bifone, A., Gandolfo, P., Costantino, L., Giordano, L., Mormone, E., Macula, A., Cuomo, M., Difruscolo, R., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13144130 · Cited by 83
Frailty Trajectories Preceding Dementia in the US and UK
Ward, D. D., Flint, J. P., Littlejohns, T. J., Foote, I. F., Canevelli, M., Wallace, L. M. K., Gordon, E. H., Llewellyn, D. J., Ranson, J. M., Hubbard, R. E., et al. (2024) · JAMA Neurology · doi:10.1001/jamaneurol.2024.3774 · Cited by 80
AI-driven fusion of multimodal data for Alzheimer’s disease biomarker assessment
Jasodanand, V. H., Kowshik, S. S., Puducheri, S., Romano, M. F., Xu, L., Au, R., & Kolachalama, V. B. (2025) · Nature Communications · doi:10.1038/s41467-025-62590-4 · Cited by 94
Alzheimer’s disease biomarkers and their current use in clinical research and practice
Hunter, T., Santos, L. E., Tovar-Moll, F. F., & Felice, F. G. D. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02709-z · Cited by 87
Rash, B. G., Ramdas, K. N., Agafonova, N., Naioti, E., McClain‐Moss, L., Zainul, Z., Varnado, B., Peterson, K., Brown, M. T., Leal, T., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03559-0 · Cited by 84
Choroid plexus volume as a novel candidate neuroimaging marker of the Alzheimer’s continuum
Jiang, J., Zhuo, Z., Wang, A., Li, W., Jiang, S., Duan, Y., Ren, Q., Zhao, M., Wang, L., Yang, S., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01520-w · Cited by 74
Self-citationA practical overview of the use of amyloid-PET Centiloid values in clinical trials and research
Iaccarino, L., Burnham, S. C., Tunali, I., Wang, J., Navitsky, M. A., Arora, A., & Pontecorvo, M. J. (2025) · NeuroImage Clinical · doi:10.1016/j.nicl.2025.103765 · Cited by 73
Fluid-based biomarkers for neurodegenerative diseases
Cao, Y., Xu, Y., Cao, M., Chen, N., Zeng, Q., Lai, M. K. P., Fan, D., Sethi, G., & Cao, Y. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102739 · Cited by 68
Nam, Y., Shin, S. J., Kumar, V., Won, J., Kim, S., & Moon, M. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00479-4 · Cited by 66
Plasma proteomic evidence for increased β-amyloid pathology after SARS-CoV-2 infection
Duff, E. P., Zetterberg, H., Heslegrave, A., Dehghan, A., Elliott, P., Allen, N. E., Runz, H., Laban, R., Veleva, E., Whelan, C. D., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03426-4 · Cited by 66
Ding, J., Zhao, C., Hao, X., & Jiao, H. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70709 · Cited by 58
Self-citationThe impact of physical exercise on neuroinflammation mechanism in Alzheimer’s disease
Hu, J., Huang, B., & Chen, K. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1444716 · Cited by 59
Schöll, M., Vrillon, A., Ikeuchi, T., Quevenco, F. C., Iaccarino, L., Vasileva-Metodiev, S. Z., Burnham, S. C., Hendrix, J. A., Epelbaum, S., Zetterberg, H., et al. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2024.100056 · Cited by 52
Reparaz-Escudero, I., Izquierdo, M., Bischoff-Ferrari, H. A., Martínez-Lage, P., & Sáez de Asteasu, M. L. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102463 · Cited by 45
Lemche, E., Killick, R., Mitchell, J., Caton, P., Choudhary, P., & Howard, J. K. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106485 · Cited by 54
Bashir, B., Gulati, M., Vishwas, S., Gupta, G., Dhanasekaran, M., Paudel, K. R., Chellappan, D. K., Anand, K., Negi, P., Singh, P. K., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102689 · Cited by 47
Paolis, M. L. D., Paoletti, I., Zaccone, C., Capone, F., D’Amelio, M., & Krashia, P. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00423-y · Cited by 49
Association of rapid eye movement sleep latency with multimodal biomarkers of Alzheimer's disease
Jin, J., Chen, J., Cavaillès, C., Yaffe, K. S., Winer, J. R., Stankeviciute, L. S., Lucey, B. P., Zhou, X., Gao, S., Peng, D., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14495 · Cited by 44
The Amyloid Cascade Hypothesis
Castellani, R. J., Jamshidi, P., Plascencia‐Villa, G., & Perry, G. L. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.10.014 · Cited by 45
The mechanisms, hallmarks, and therapies for brain aging and age-related dementia
Jin, S., Lü, W., Zhang, J., Zhang, L., Tao, F., Zhang, Y., Hu, X., & Liu, Q. (2024) · 中国科学通报:英文版 · doi:10.1016/j.scib.2024.09.005 · Cited by 43
Self-citationThe Impact of Cognitive Impairment on Cardiovascular Disease
Jamil, Y., Krishnaswami, A., Orkaby, A. R., Stimmel, M. B., Brown, C. H., Mecca, A. P., Forman, D. E., Rich, M. W., Nanna, M. G., & Damluji, A. A. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.04.057 · Cited by 46
Roles of TREM2 in Alzheimer’s disease
Qi, X., Zhu, K., Ke, W., Wang, J., Mao, S., & Chen, G. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00515-3 · Cited by 42
Joy, M. A. M., Nasrin, S., Siddiqua, A., & Farid, D. M. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149302 · Cited by 49
Tsering, W., de la Rosa, A., Ruan, I. Y., Philips, J. L., Bathe, T., Villareal, J. A. B., & Prokop, S. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16275 · Cited by 34
High-dimensional proteomic analysis for pathophysiological classification of traumatic brain injury
Li, L. M., Kodosaki, E., Heslegrave, A., Zetterberg, H., Graham, N., Zimmerman, K. A., Soreq, E., Parker, T. D., Garbero, E., Moro, F., et al. (2024) · Brain · doi:10.1093/brain/awae305 · Cited by 33
Mengel, D., Soter, E., Ott, J. M., Wacker, M., Leyva, A., Peters, O., Hellmann‐Regen, J., Schneider, L., Wang, X., Priller, J., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03021-0 · Cited by 33
Recent advances in neuroimaging of Alzheimer's disease and related dementias
Ottoy, J., Owsicki, N., Bilgel, M., Binette, A. P., Salvadó, G., Kang, M. S., Cash, D. M., Ewers, M., Joie, R. L., Wisse, L. E. M., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70648 · Cited by 39
Discovery of novel butyrylcholinesterase inhibitors for treating Alzheimer's disease
Sang, Z., Huang, S., Tan, W., Ban, Y., Wang, K., Fan, Y., Chen, H., Zhang, Q., Liang, C., Mi, J., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.02.030 · Cited by 33
Hyperspectral retinal imaging in Alzheimer’s disease and age-related macular degeneration: a review
Du, X., Park, J., Zhao, R., Smith, R. T., Koronyo, Y., Koronyo‐Hamaoui, M., & Gao, L. S. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01868-y · Cited by 30
The Energetic Collapse of the Alzheimer's Brain: Metabolic Inflexibility Across Cells and Networks
Constantino, N. J., Ashley, C. C., & Macauley, S. L. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70294 · Cited by 31
Fang, S., Zhang, K., Liu, D., Yang, Y., Hu, X., Xie, W., Diao, K., Rao, Z., Wang, D., & Yang, W. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1408620 · Cited by 28
Cognitive modeling of the Mnemonic Similarity Task as a digital biomarker for Alzheimer's disease
Vanderlip, C. R., Lee, M. D., & Stark, C. E. L. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14163 · Cited by 31
Central Nervous System-Derived Extracellular Vesicles as Biomarkers in Alzheimer’s Disease
Yu, Y., Wang, Z., Chai, Z., Ma, S., Li, A., & Li, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178272 · Cited by 26
Self-citationThe prion principle and Alzheimer’s disease
Walker, L. C., & Jucker, M. (2024) · Science · doi:10.1126/science.adq5252 · Cited by 25
Identification of early Alzheimer’s disease subclass and signature genes based on PANoptosis genes
Wang, W., Lu, J., Pan, N., Zhang, H., Dai, J., Li, J. P., Chi, C., Zhang, L., Wang, L., & Zhang, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1462003 · Cited by 28
Cerebrospinal fluid proteomics identification of biomarkers for amyloid and tau PET stages
Wang, Z., Chen, Y., Gong, K., Zhao, B., Ning, Y., Chen, M., Li, Y., Ali, M., Timsina, J., Liu, M., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102031 · Cited by 31
Self-citationKang, M. J., Grewal, J. K., Eratne, D., Malpas, C. B., Chiu, W.-H. M., Katisko, K., Solje, E., Santillo, A. F., Mitchell, P. B., Hopwood, M., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.11.001 · Cited by 24
Cerebrospinal Fluid Amyloid and Tau Biomarker Changes Across the Alzheimer Disease Clinical Spectrum
de Leeuw, D. M., Trieu, C., Vromen, E. M., Blujdea, E. R., Verberk, I. M. W., Duits, F. H., Teunissen, C. E., Pijnenburg, Y. A. L., van der Flier, W. M., van Harten, A. C., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.19919 · Cited by 27
Plasma proteomic associations with Alzheimer’s disease endophenotypes
Afshar, S., Dammer, E. B., Bian, S., Bennett, D. A., Mohs, R. C., Beauregard, D., Dwyer, J. R., Hales, C. M., Goldstein, F. C., Parker, M. W., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00965-4 · Cited by 30
Abbatecola, A. M., Giuliani, A., Biscetti, L., Scisciola, L., Battista, P., Barbieri, M., Sabbatinelli, J., & Olivieri, F. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102257 · Cited by 23
Cardiometabolic Trajectories Preceding Dementia in Community-Dwelling Older Individuals
Wu, Z., Cribb, L., Wolfe, R. S., Shah, R. C., Orchard, S. G., Owen, A. J., Woods, R. L., Vishwanath, S., Chong, T. T. ‐., Sheets, K. M., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.58591 · Cited by 22
Reho, P., Kalia, V., Jackson, G. L., Wang, F., Eiten, E., Brennan, K. J. M., Brickman, A. M., Mayeux, R. P., Miller, G. W., Vardarajan, B. N., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70050 · Cited by 22
Jiao, B., Ouyang, Z., Liu, Y., Zhang, C., Xu, T., Yang, Q., Zhang, S., Zhu, Y., Wan, M., Xiao, X., et al. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01712-y · Cited by 22
Immunotherapy: An emerging treatment option for neurodegenerative diseases
Mukherjee, A., Biswas, S., & Roy, I. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.103974 · Cited by 23
Uchida, Y., Nishimaki, K., Soldan, A., Pettigrew, C. A., Ho, S. G., Moghekar, A., Wang, M., Miller, M. I., Albert, M., & Oishi, K. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70544 · Cited by 26
Haniff, Z. R., Bocharova, M., Mantingh, T., Rucker, J., Velayudhan, L., Taylor, D. M., Young, A. H., Aarsland, D., Vernon, A. C., & Thuret, S. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108641 · Cited by 22
Amyloid-beta metabolism in age-related neurocardiovascular diseases
Aivalioti, E., Georgiopoulos, G. A., Tual‐Chalot, S., Bampatsias, D., Delialis, D., Sopova, K., Drakos, S. G., Stellos, K., & Stamatelopoulos, K. S. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae655 · Cited by 24
Estimating the time course of biomarker changes in Alzheimer’s disease
Rakêt, L. L., Binette, A. P., Mattsson, N., Janelidze, S., Zetterberg, H., Ashton, N. J., Blennow, K., Stomrud, E., Palmqvist, S., & Hansson, O. (2025) · Brain · doi:10.1093/brain/awaf413 · Cited by 23
Викторовна, Ш. К., Олегович, Р. Д., Гришина, Д. А., Grinyuk, V. V., Zakharov, V. V., Kashakanova, N. M., Koberskaya, N. N., Kosivtsova, O. V., Борисовна, Л. А., Starchina, Y. A., et al. (2024) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2024-3-96-102 · Cited by 20
Schaap, T., Thropp, P., Tosun, D., & Initiative, A. D. N. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14306 · Cited by 20
Ai, M., Liu, Y., Liu, D., Yan, C., Wang, X., & Chen, X. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1596632 · Cited by 22
Amyloid PET disclosure in subjective cognitive decline: Patient experiences over time
Hendriksen, H. M. A., de Rijke, T. J., Fruijtier, A. D., van de Giessen, E., van Harten, A. C., van Leeuwenstijn‐Koopman, M. S. S. A., van der Schaar, J., Trieu, C., Visser, D., Smets, E. M. A., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14148 · Cited by 18
The AROMHA brain health test is a remote olfactory assessment to screen for cognitive impairment
Jobin, B., Magdamo, C., Delphus, D., Runde, A., Reineke, S., Alejandro-Soto, A., Ergun, B., Mukhija, S., Albers, A. D., & Albers, M. W. (2025) · Scientific Reports · doi:10.1038/s41598-025-92826-8 · Cited by 18
Li, H., Xiao, Q., Zhu, L., Kang, J. S., Zhan, Q., & Peng, W. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.101106 · Cited by 17
Neuroinflammation and nutrition in Alzheimer’s disease
Park, H., Ni, M., & Le, Y. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1622571 · Cited by 17
Barbera, L. L., Krashia, P., Loffredo, G., Cauzzi, E., Paolis, M. L. D., Montanari, M., Saba, L., Spoleti, E., Ficchì, S., Zaccone, C., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00893-2 · Cited by 17
Lysophosphatidylcholines are associated with amyloidosis in early stages of Alzheimer’s disease
Kalia, V., Reyes‐Dumeyer, D., Dubey, S., Udhani, H. H., Nandakumar, R., Lee, A., Lantigua, R., Medrano, M. Z., Rivera, D., Honig, L. S., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-01025-7 · Cited by 18
Goel, H., Rana, I., Jain, K., Ranjan, K. R., & Mishra, V. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb01293c · Cited by 17
Wu, J., Li, B., Wang, J., Huang, Q., Chen, X., You, Z., He, K., Guo, Q., Li, S., Huang, Y. H., et al. (2024) · Radiology · doi:10.1148/radiol.233019 · Cited by 17
Jutten, R. J., Soberanes, D., Molinare, C. P., Hsieh, S., Farrell, M. E., Schultz, A. P., Rentz, D. M., Marshall, G. A., Johnson, K. A., Sperling, R. A., et al. (2025) · npj Digital Medicine · doi:10.1038/s41746-024-01347-7 · Cited by 17
Fully Integrated Wearable Biosensor for Multiple In Situ Phosphorylated Tau Protein Detection
Sun, X., Zhong, G., Zeng, Y., Xu, T., & Liu, Y. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c02541 · Cited by 16
Appiah, D., Ingabire-Gasana, E., Appiah, L., & Yang, J. (2024) · Nutrients · doi:10.3390/nu16111672 · Cited by 16
Cerebral amyloid angiopathy and the immune system
Munsterman, D., Falcione, S. R., Long, R., Boghozian, R., Joy, T., Camicioli, R. M., Smith, E. E., & Jickling, G. C. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13826 · Cited by 17
Real-world evidence: state-of-the-art and future perspectives
Fitzke, H., Fayzan, T., Watkins, J. D., Galimov, E. R., & Pierce, B. F. (2025) · Journal of Comparative Effectiveness Research · doi:10.57264/cer-2024-0130 · Cited by 16
Yan, Z.-J., Ye, M., Li, J., Zhang, D., & Yao, Y. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00853-w · Cited by 17
Hey, J. A., Yu, Y., Abushakra, S. R., Schaefer, J. F., Power, A., Kesslak, P. J., & Tolar, M. (2024) · Drugs · doi:10.1007/s40265-024-02068-7 · Cited by 16
Extracellular vesicles‐based theranostics for neurodegenerative diseases
Zhao, H., Zhu, L., Wang, C., & Yang, Y. (2024) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1993 · Cited by 17
Viña, J., Borrás, C., & Mas‐Bargues, C. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240308 · Cited by 15
Umoh, M. E., Yan, H., Leoutsakos, J., Lewis, A., Marcantonio, E. R., Lyketsos, C. G., Inouye, S. K., Moghekar, A., Neufeld, K. J., Rosenberg, P. B., et al. (2024) · Journal of the Academy of Consultation-Liaison Psychiatry · doi:10.1016/j.jaclp.2024.10.002 · Cited by 16
Browne, D. F., Smirnov, D. S., Coughlin, D. G., Peng, I., Standke, H. G., Kim, Y., Pizzo, D. P., Unapanta, A., Andreasson, T., Hiniker, A. O., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56469-7 · Cited by 16
Pokrzyk, J., Kulczyńska‐Przybik, A., Guzik-Makaruk, E. M., Winkel, I., & Mroczko, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051935 · Cited by 16
Luo, C., Zhu, X., Zhang, Y., Wen, Y., Wan, L., & Qian, Z. (2025) · Talanta · doi:10.1016/j.talanta.2025.128009 · Cited by 15
Ioannidou, S., Tsolaki, M., Ginoudis, A., Tamvakis, Α., Tsolaki, A., Makedou, K., & Lymperaki, E. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15050171 · Cited by 15
Bangs, M. C., Gadhavi, J. D., Carter, K., Ping, L., Duong, D. M., Dammer, E. B., Wu, F., Shantaraman, A., Fox, E. J., Johnson, E. C. B., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70830 · Cited by 17
Peripheral immune and metabolic regulation of Aβ and Tau by exercise in Alzheimer’s disease
Yu, Y., & Chen, K. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1678526 · Cited by 14
Prediction and Prevention of Inflammatory Bowel Disease
Lopes, E. W., Turpin, W., Croitoru, K., Colombel, J., & Torres, J. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.05.047 · Cited by 15
Li, X.-L., Lin, Z.-H., Chen, S., Ni, S., Lin, G., Wang, W., Lin, J.-Y., Zhao, Q., Cong, C., & Xu, L. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156391 · Cited by 14
Lu, Y., Xu, Y., Zhou, L., Wang, S., Han, Y., Wang, K., & Qin, C. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04131-w · Cited by 14
Self-citationPan, F., Huang, Q., Huang, C., Lu, Y. W., Cui, L., Huang, L., Guan, Y., Xie, F., & Guo, Q. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70005 · Cited by 14
Okita, Y., Shimomura, Y., Komukai, S., Zha, L., Komatsu, M., Kimura, Y., Gon, Y., Murata, F., Maeda, M., Kiyohara, K., et al. (2025) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.70036 · Cited by 14
Brain health concerns in former rugby players: clinical and cognitive phenotypes
Parker, T. D., Hain, J., Rooney, E. J., Zimmerman, K. A., Lee, Y., Giovane, M. D., Graham, N., Patel, M. C., Hampshire, A., Wilson, M. G., et al. (2025) · Brain · doi:10.1093/brain/awae416 · Cited by 13
Titze-de-Almeida, S. S., Marina, C. L., Ramos, M. V., Silva, L. D. D. S., Brandão, P. R. D. P., Bispo, D. D. D. C., von Glehn, F., & Titze‐de‐Almeida, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178246 · Cited by 13
Chen, Y., Zeng, X., Olvera‐Rojas, M., Sewell, K. R., Sehrawat, A., Gu, J. M., Triviño‐Ibáñez, E. M., Solis‐Urra, P., Gómez-Río, M., Oberlin, L. E., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68372-w · Cited by 13
Neurofilament Light Chain as Biomarker in Encephalitis
Wellmann, S. M., Geis, T., Kühle, J., & Lehnerer, V. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13185416 · Cited by 13
PET/CT/MRI in Clinical Trials of Alzheimer’s Disease
Høilund‐Carlsen, P. F., Alavi, A. A., & Barrio, J. R. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240206 · Cited by 13
Lan, W., Zhao, J., Zhai, X., Gu, C., Jiang, T., & Wang, J. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.114665 · Cited by 12
Iwatsubo, T., Sperling, R. A., Algeciras‐Schimnich, A., Arai, H., Barron, A. M., Benzinger, T. L. S., Carrillo, M. C., Chen, C., Choi, S. H., Fontana, I. C., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70536 · Cited by 13
Self-citationStudart‐Neto, A., Barbosa, B. J. A. P., Coutinho, A. M., de Souza, L. C., Schilling, L. P., da Silva, M. N. M., Castilhos, R. M., Bertolucci, P. H. F., Borelli, W. V., Gomes, H. R., et al. (2024) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2024-c001 · Cited by 15
Adaptive spatiotemporal encoding network for cognitive assessment using resting state EEG
Sun, J., Shen, A., Sun, Y., Chen, X., Li, Y., Gao, X., & Lu, B. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01384-2 · Cited by 11
Self-citation
Metadata
- Authors
- Jia, J., Ning, Y., Chen, M., Wang, S., Yang, H., Li, F., Ding, J., Li, Y., Zhao, B., Lyu, J., Yang, S., Yan, X., Wang, Y., Qin, W., Wang, Q., Li, Y., Zhang, J., Liang, F., Liao, Z., & Wang, S.
- Affiliations
- Capital Medical University (CN)
- From the Innovation Center for Neurological Disorders, Department of Neurology, Xuanwu Hospital (J.J., Y.N., M.C., Shuheng Wang, H.Y., F. Li, J.D., Yan Li, B.Z., W.Q., Q.W., Ying Li), Beijing Key Laboratory of Geriatric Cognitive Disorders, Clinical Center for Neurodegenerative Disease and Memory Impairment (J.J.), the Center of Alzheimer’s Disease, Beijing Institute of Brain Disorders, Collaborative Innovation Center for Brain Disorders (J.J.), and the Department of Neurology, Beijing Anding Hospital (Y.W.), Capital Medical University, Key Laboratory of Neurodegenerative Diseases, Ministry of Education (J.J.), the Center for Cognitive Disorders, Beijing Geriatric Hospital (J.L.), and the Department of Neurology, Beijing Jishuitan Hospital (X.Y.), Beijing, the Department of Neurology, Daqing Oilfield General Hospital, Daqing (S.Y.), the Department of Neurology, the 960th Hospital of the People’s Liberation Army, Jinan (J.Z.), the Department of Neurology, Baotou Central Hospital, Baotou (F. Liang), the Depa...
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2024-02-22
- Volume
- 390
- Issue
- 8
- Pages
- 712-722
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4391990232
- Cited by
- 455
- References
- 33
- Citations by year
- 2026: 162 · 2025: 202 · 2024: 91
- FWCI
- 133.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (30370494, 30410303095, 30470615)
- Mission Program of Beijing Municipal Administration of Hospitals (SML20150801)
- Beijing Natural Science Foundation (7071004)
- The National Science and Technology Foundation of China (2003CB517102, 2004BA714B06-1, 2006BAI02B01, 2006CB500700, 2011CB504101, 2011ZX09307-001-03)
- Sailing Plan of Beijing Municipal Administration of Hospitals (ZY201301)
- Major project of Beijing Municipal Science and Technology Commission (D111107003111009)
- Beijing Brain Initiative from Beijing Municipal Science & Technology Commission (Z201100005520017, Z161100000216137, Z201100005520016)
- Key Project of the National Natural Science Foundation of China (81530036, U20A20354)
- National Key Scientific Instrument and Equipment Development Projects of China (31627803)
- National major R&D projects of China-Scientific technological innovation 2030 (2021ZD0201802)
- CHINACANADA Joint Initiative on Alzheimer’s Disease and Related Disorders (81261120571)
- Beijing Scholars Program
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- Alzheimer's disease, preclinical Alzheimer's disease, cerebrospinal fluid biomarkers, amyloid-beta 42, phosphorylated tau 181, total tau, neurofilament light chain, hippocampal volume, cognitive decline, sporadic Alzheimer's disease
- MeSH terms
- Alzheimer Disease, Follow-Up Studies, Humans, Biomarkers, Case-Control Studies, Amyloid beta-Peptides, tau Proteins, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.